• HR+/HER2 neg4
• HER2+0
• TNBC0

• Protocols

• UW24161

  OPEN TO ACCRUAL

  REDEFINE Study - Safety and Effectiveness of GORE Tissue Reinforcement for Breast Reconstruction
  
  

• UW25099

  OPEN TO ACCRUAL

  Ph1 Study of MEN2312, a KAT6 Inhibitor, as Monotherapy and in Combination in Pts w Adv Breast Cancer